AstraZeneca Pharma - ASTRAZEN, 506820 corporate action history

AstraZeneca Pharma India Ltd. NSE: ASTRAZEN | BSE: 506820

Expensive Performer

Download real time

8340.00 -78.50 (-0.93%)

25.99% Gain from 52W Low

8,656

NSE+BSE Volume

NSE 09 Jan, 2026 3:31 PM (IST)

AstraZeneca Pharma Bonus history

AstraZeneca Pharma has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Split history for AstraZeneca Pharma

AstraZeneca Pharma has split the face value 1 time since June 15, 2006. AstraZeneca Pharma had last split the face value of its shares from ₹10 to ₹2 in 2006.The share has been quoting on an ex-split basis from June 15, 2006.

Ex-Date	Old FV	New FV	Record Date
15 Jun 2006	10	2	22 Jun 2006

See all forthcoming Bonus and split

Dividend history for AstraZeneca Pharma

AstraZeneca Pharma has declared 17 dividends since April 17, 2003.

In the past 12 months, AstraZeneca Pharma has declared an equity dividend amounting to ₹32.00 per share.

At the current share price of ₹8340.0000, AstraZeneca Pharma's dividend yield is 0.38%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
18 Jul 2025	32.00	FINAL	18 Jul 2025	Equity Share
05 Jul 2024	24.00	FINAL	05 Jul 2024	Equity Share
14 Jul 2023	16.00	FINAL	14 Jul 2023	Equity Share
07 Jul 2022	8.00	FINAL	08 Jul 2022	Equity Share
18 Aug 2021	2.00	INTERIM	20 Aug 2021	Equity Share
20 Aug 2020	2.00	INTERIM	21 Aug 2020	Equity Share
20 Aug 2019	1.00	INTERIM	21 Aug 2019	Equity Share
09 Jul 2012	3.50	FINAL	-	Equity Share
07 Jul 2011	10.00	FINAL	-	Equity Share
06 May 2010	10.00	FINAL	-	Equity Share
29 Apr 2009	15.00	FINAL	-	Equity Share
11 Apr 2008	15.00	FINAL	-	Equity Share
22 Mar 2007	12.00	INTERIM	24 Mar 2007	Equity Share
12 Apr 2006	20.00	FINAL	-	Equity Share
18 Mar 2005	50.00	FINAL	-	Equity Share
16 Apr 2004	3.90	FINAL	-	Equity Share
17 Apr 2003	3.70	FINAL	-	Equity Share

VIEW MORE

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - AstraZeneca Pharma

The latest board meeting for AstraZeneca Pharma took place on 07 Nov 2025, for the purpose of Quarterly Results

Ex-Date	Purpose	Notes
07 Nov 2025	Quarterly Results	-
14 Aug 2025	Quarterly Results	-
30 May 2025	Audited Results & Dividend	-
11 Feb 2025	Quarterly Results	-
13 Nov 2024	Quarterly Results	-
08 Aug 2024	Quarterly Results	-
27 May 2024	Audited Results & Dividend	-
08 Feb 2024	Quarterly Results	-
09 Nov 2023	Quarterly Results	-
14 Aug 2023	Quarterly Results	-

See all Board Meetings for AstraZeneca Pharma

AstraZeneca Pharma Rights history

AstraZeneca Pharma has not issued any rights since Jan 1, 2000.

See all Rights History for AstraZeneca Pharma

Is AstraZeneca Pharma India Ltd. worth buying?

150 Votes:

Buy 71.33%

Sell 19.33%

Hold 9.33%